A drug used to reduce sugar levels in diabetics appears to be useful in delaying or even preventing the disease in people predisposed to developing diabetes, a study in Japan has found. The study, published in The Lancet, found that fewer people who were given the generic drug voglibose went on to develop diabetes compared to those who received placebo, or dummy lookalike pills with no therapeutic value.
While the study was supposed to last three years, researchers found that voglibose was much better than placebo before the end of the first year, and an independent monitoring panel terminated the study early. "Long term prophylaxis with this (drug) in high-risk individuals with impaired glucose tolerance could provide a pharmacological option, along with lifestyle modification, to help reduce the burden of type 2 diabetes in Japan," the researchers wrote in the article...read more
Friday, 26 June 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment